Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against GeneDx Holdings Corp. and certain officers, alleging violations of federal securities laws. The suit covers investors who purchased or acquired GeneDx securities between April 16, 2025 and May 4, 2026. The complaint claims the company made false and misleading statements and failed to disclose that it may have misled investors about the importance of Fabric Genomics, that margins would suffer, that average reimbursement rates were not as durable as previously disclosed, and that gross margins would decline. Investors have until August 3, 2026 to seek lead plaintiff appointment. The firm represents investors on a contingency fee basis.
GeneDx Holdings Corp.Class action lawsuit alleging securities fraud and misleading disclosures.